BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20193108)

  • 1. Technology update for the sorting and identification of breast cancer stem cells.
    Chen J; Chen ZL
    Chin J Cancer; 2010 Mar; 29(3):265-9. PubMed ID: 20193108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells.
    Oh PS; Patel VB; Sanders MA; Kanwar SS; Yu Y; Nautiyal J; Patel BB; Majumdar AP
    Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G347-55. PubMed ID: 21596996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic characteristics of the side population of human small cell lung cancer cell line H446.
    Wang B; Yang H; Huang YZ; Yan RH; Liu FJ; Zhang JN
    Chin J Cancer; 2010 Mar; 29(3):254-60. PubMed ID: 20193106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor recurrence and drug resistance properties of side population cells in high grade ovary cancer.
    Zhang QH; Dou HT; Xu P; Zhuang SC; Liu PS
    Drug Res (Stuttg); 2015 Mar; 65(3):153-7. PubMed ID: 25504004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colon cancer stem cells: implications in carcinogenesis.
    Sanders MA; Majumdar AP
    Front Biosci (Landmark Ed); 2011 Jan; 16(5):1651-62. PubMed ID: 21196254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress of research on breast cancer stem cell markers].
    Liu X; Li W; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):282-4. PubMed ID: 24915825
    [No Abstract]   [Full Text] [Related]  

  • 7. [Progress and prospects in cancer stem cell research for hepatocellular carcinoma].
    Xu W; Cao L; Yin ZF
    Ai Zheng; 2009 Sep; 28(9):1004-8. PubMed ID: 19728923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCG2 is a potential marker of tumor-initiating cells in breast cancer.
    Sicchieri RD; da Silveira WA; Mandarano LR; de Oliveira TM; Carrara HH; Muglia VF; de Andrade JM; Tiezzi DG
    Tumour Biol; 2015 Dec; 36(12):9233-43. PubMed ID: 26091795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD133 and ALDH may be the molecular markers of cholangiocarcinoma stem cells.
    Wang M; Xiao J; Jiang J; Qin R
    Int J Cancer; 2011 Apr; 128(8):1996-7. PubMed ID: 20568110
    [No Abstract]   [Full Text] [Related]  

  • 10. [Identification and isolation of cancer stem cells from A549 cells].
    Xia H; Yu C; Zhang W; Zhang B; Zhao Y; Fang F
    Zhongguo Fei Ai Za Zhi; 2013 Aug; 16(8):400-4. PubMed ID: 23945242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
    Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS
    Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying tumor stem-like cells in mouse melanoma cell lines by analyzing the characteristics of side population cells.
    Dou J; Wen P; Hu W; Li Y; Wu Y; Liu C; Zhao F; Hu K; Wang J; Jiang C; He X; Gu N
    Cell Biol Int; 2009 Aug; 33(8):807-15. PubMed ID: 19477285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
    Alberti L; Losi L; Leyvraz S; Benhattar J
    PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lineage relationship of prostate cancer cell types based on gene expression.
    Pascal LE; Vêncio RZ; Vessella RL; Ware CB; Vêncio EF; Denyer G; Liu AY
    BMC Med Genomics; 2011 May; 4():46. PubMed ID: 21605402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of the putative cancer stem cell markers ABCG2, CD133, ALDH1A1 and CD44V7/8 in metastatic melanoma.
    Speigl L; Janssen N; Weide B; Pawelec G; Shipp C
    Br J Dermatol; 2017 Nov; 177(5):1447-1449. PubMed ID: 27870003
    [No Abstract]   [Full Text] [Related]  

  • 16. Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck.
    Okamoto A; Chikamatsu K; Sakakura K; Hatsushika K; Takahashi G; Masuyama K
    Oral Oncol; 2009 Jul; 45(7):633-9. PubMed ID: 19027347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary analysis of stem cell-like cells in human neuroblastoma.
    Xing LL; Sha YL; Wu YM; Hu JM; Zhang M; Lv F
    World J Pediatr; 2015 Feb; 11(1):54-60. PubMed ID: 25431041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.
    Currie MJ; Beardsley BE; Harris GC; Gunningham SP; Dachs GU; Dijkstra B; Morrin HR; Wells JE; Robinson BA
    Hum Pathol; 2013 Mar; 44(3):402-11. PubMed ID: 23036368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side population cells and drug resistance in breast cancer.
    Wang M; Wang Y; Zhong J
    Mol Med Rep; 2015 Jun; 11(6):4297-302. PubMed ID: 25647733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem cells hypothesis and stem cells in head and neck cancers.
    Mannelli G; Gallo O
    Cancer Treat Rev; 2012 Aug; 38(5):515-39. PubMed ID: 22197808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.